Abstract: A heat sink according to an example embodiment comprises: an inlet part through which a refrigerant is introduced; an outlet part through which the refrigerant received from the inlet part is discharged; and a plurality of flow channels disposed between the inlet part and the outlet part, configured to allow the refrigerant to flow, wherein the plurality of flow channels is arranged to have a spirally bent shape, and parts of the plurality of flow channels communicate with each other to allow the refrigerant to circulate between the flow channels.

Abstract: The present disclosure relates to a method and apparatus enabling setting of I/O parameters for communication between a system-on-chip and a memory.

Abstract: The present invention relates to a pipe blockage handling device comprising: a main body part in which high-pressure air capable of removing foreign substances blocking a pipe can accumulate, and which accommodates an accumulator; an air compressor which is connected to one side of the main body part and causes air to accumulate inside the main body part, thereby increasing the air pressure and amount of air accumulated in the main body part; a pipe insertion part which is connected to an end of the main body part and expands to a certain volume and shape when injected with the air accumulated in the main body part, wherein the pipe insertion part can seal the inside and outside of a blocked pipe by deforming to conform to the shape of an inlet of the blocked pipe when pressed against the inlet of the blocked pipe, and can seal the inside and outside of the blocked pipe by expanding to conform to the size and shape of the inside of the pipe and coming into close contact with the inner circumferential surface

Abstract: Provided herein are molecules having an antigen binding fragment that immunospecifically binds to BTN1A1, such as anti-BTN1A1 antibodies. These molecules include those having an antigen binding fragment that immunospecifically binds to BTN1A1 dimers, such as anti-BTN1A1 dimer antibodies. Methods of making and using these molecules are also provided, including methods of using them in cancer therapies, or as cancer diagnostics.

Abstract: A non-oriented electrical steel sheet according to an embodiment of the present invention includes, in wt %, Si at 0.2 to 4.3%, Mn at 0.05 to 2.5%, Al at 0.1 to 2.1%, Bi at 0.0001 to 0.003%, Ga at 0.0001 to 0.003%, and the balance of Fe and inevitable impurities.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Abstract: A non-oriented electrical steel sheet according to an embodiment of the present invention includes: in wt %, C at 0.004 wt % or less (excluding 0 wt %), Si at 2.5 to 4.0 wt %, P at 0.1 wt % or less (excluding 0 wt %), Al at 0.3 to 2.0 wt %, N at 0.003 wt % or less (excluding 0 wt %), S at 0.003 wt % or less (excluding 0 wt %), Mn at 0.15 to 2.5 wt %, Cr at 0.5 wt % (excluding 0 wt %), and the balance including Fe and other impurities unavoidably added thereto; satisfies the following Equation 1; and has an average grain size of 20 ?m or less. [Mn]?1450×[S]?0.8??[Equation 1] (In Equation 1, [Mn] and [S] represent a content (wt %) of Mn and S, respectively.).

Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.

Abstract: The present invention relates to a non-grain-oriented electrical steel sheet which is excellent in high-frequency iron loss, and a manufacturing method thereof. A non-grain-oriented electrical steel sheet according to an exemplary embodiment of the present invention includes 2.5 to 3.8 wt % of Si, 0.5 to 2.5 wt % of Al, 0.2 to 4.5 wt % of Mn, 0.0005 to 0.02 wt % of As, 0.0005 to 0.01 wt % of Bi, the balance Fe, and inevitable impurities, and satisfies the following [Equation 1]. 0.3?[surface fine crystal grain diameter]×[fine grain formation thickness]×([As]/[Bi])?5.0??[Equation 1] In Equation 1, [surface fine crystal grain diameter] means an average particle diameter (?m) of fine crystal grains in an electrode surface layer of an electrical steel sheet, [fine grain formation thickness] means a thickness (mm) of an electrode surface layer in which fine crystal grains are formed, and [As] and [Bi] mean a composition (wt %) of As and a composition (wt %) of Bi, respectively.

Abstract: A non-oriented electrical steel sheet according to an exemplary embodiment of the present invention contains, by wt %: 0.005% or less (excluding 0%) of C, 1.5 to 3.0% of Si, 0.4 to 1.5% of Mn, 0.005% or less (excluding 0%) of S, 0.0001 to 0.7% of Al, 0.005% or less (excluding 0%) of N, 0.005% or less (excluding 0%) of Ti, 0.001 to 0.02% of Cu, 0.01 to 0.05% of Sb, 0.001 to 0.1% of Sn, and 0.005 to 0.07% of P, wherein contents of Mn, Si, and Al satisfy the following [Expression 1], contents of Sb, Sn, and P satisfy the following [Expression 2], the non-oriented electrical steel sheet contains a balance of Fe and unavoidably incorporated impurities, and the number of (Mn, Cu)S precipitates of 0.5 ?m or less per area is 1/?m3 or less: 0.19 ? [ Mn ] / ( [ Si ] + 150 × [ Al ] ) ? 0.35 [ Expression ? 1 ] 1 / 2 * ? Sn < [ Sb ] + [ P ] < 0 . 0 ? 9 .

Abstract: Antibodies that selectively bind to glycosylated PD-1 relative to unglycosylated PD-1 are provided. In some aspects, PD-1 polypeptides comprising glycosylated amino acid positions are also provided. Methods for making and using such antibodies and polypeptides (e.g., for the treatment of cancer) are also provided.

Abstract: Techniques are described for a bypass switch that includes: a switch body having a column; a switch head which is coupled to the column and in which a sliding part is provided; a sliding part which is inserted into the switch head; a driven latch which is inserted into the sliding part and fixed to a driving shaft penetrating therethrough; a driving latch which is coupled to an end of the driving shaft exposed to an outside of the switch head, and which is provided to be driven by a solenoid; a stop coupled to the front of the switch head; a pressure bearing which is inserted into a lower portion of the sliding part and coupled thereto by a bearing pin; an elastic body provided between the sliding part and the switch body; and a rod coupled to an upper portion of the sliding part.

Abstract: Antibodies that selectively bind to glycosylated PD-1 relative to unglycosylated PD-1 are provided. In some aspects, PD-1 polypeptides comprising glycosylated amino acid positions are also provided. Methods for making and using such antibodies and polypeptides (e.g., for the treatment of cancer) are also provided.

Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.

Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.

Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.

Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.

Abstract: Disclosed is a mutant strain having improved aromatic amino acid production capability as a result of the inactivation or weakening of activity of asparaginase which is expressed by ansB gene.

Abstract: A heat sink according to an example embodiment comprises: an inlet part through which a refrigerant is introduced; an outlet part through which the refrigerant received from the inlet part is discharged; and a plurality of flow channels disposed between the inlet part and the outlet part, configured to allow the refrigerant to flow, wherein the plurality of flow channels is arranged to have a spirally bent shape, and parts of the plurality of flow channels communicate with each other to allow the refrigerant to circulate between the flow channels.